Clinical studies recruiting near Ancona

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Azienda Ospedaliero Universitaria delle Marche · Bristol-Myers Squibb · NCT06929273 Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Phase 3 · Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04168502 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Azienda Ospedaliero Universitaria dell Marche I G M Lancisi · Alfasigma S.p.A. · NCT06865417 PulseSelect™ PFA Global Registry
Phase N/A · Azienda Ospedaliera di Ancona · Medtronic Cardiac Ablation Solutions · NCT06393920 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Azienda Ospedaliero Universitaria delle Marche · Boehringer Ingelheim · NCT07355296 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · INRCA · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 A Socio-Technological Intervention in Community-Based Healthcare for Individuals With Mild Cognitive Impairment (DHEAL-C
NA · IRCCS INRCA Hospital · Istituto Nazionale di Ricovero e Cura per Anziani · NCT06984367 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Ospedale Pediatrico Salesi · Eli Lilly and Company · NCT07222332 Inari VISION Registry
Phase N/A · Azienda Ospedaliero Universitaria delle Marche · Inari Medical · NCT06600542 Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Seve
Phase N/A · Diabetologia Pediatrica Azienda Ospedaliero-Universitaria · Esteve Pharmaceuticals, S.A. · NCT00903110 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Azienda Ospedaliero Universitaria delle Marche -Umberto I G. · Gilead Sciences · NCT06051617 Underprescribing in Geriatric Patients: a Prevalence Study and Analysis of Factors Contributing to Potential Prescriptio
Phase N/A · IRCCS INRCA Hospital · Istituto Nazionale di Ricovero e Cura per Anziani · NCT06904638 Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Phase 2/Phase 3 · Mario Negri Institute for Pharmacological Research · NCT06126315 Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Phase 3 · A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di · Fondazione Italiana Linfomi - ETS · NCT04442412 Assessment of Venous Return During Volume Expansion: a Prospective Observational Study
Phase N/A · AOU delle Marche · Università Politecnica delle Marche · NCT07499388 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Aou Delle Marche · Takeda · NCT06499285 A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/
Phase 1 · Sanofi · NCT06630806 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Azienda Ospedaliero Universitaria delle Marche-Site Number: · Sanofi · NCT07290803 Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiov
Phase N/A · Ospedali Riuniti di Ancona · Centro Cardiologico Monzino · NCT06884631 Epidemiological Study on Invasive Bacterial Diseases
Phase N/A · Ospedali riuniti di Ancona · Meyer Children's Hospital IRCCS · NCT06322290 A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasth
Phase N/A · Azienda Ospedaliero Universitaria delle Marche · argenx · NCT07595653 Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
Phase N/A · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06806579 A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Ly
Phase N/A · AOU Ospedali Riuniti - Clinica di Ematologia · Fondazione Italiana Linfomi - ETS · NCT06008691 Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Park
Phase N/A · Azienda Ospedaliero Universitaria delle Marche /ID# 272694 · AbbVie · NCT06965374 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Im
Phase 1/Phase 2 · Azienda Ospedaliero Universitaria delle Marche /ID# 268667 · AbbVie · NCT06772623 Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C M
Phase 1/Phase 2 · Department of Medical Oncology - Azienda Ospedaliero Uniersi · Revolution Medicines, Inc. · NCT06128551 Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Te
Phase 1/Phase 2 · Azienda Ospedaliero Universitaria delle Marche · Boehringer Ingelheim · NCT06324357 Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis
Phase N/A · Ospedali Riuniti · Centro di Riferimento Oncologico - Aviano · NCT05817617 A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropeni
Phase 3 · X4 Pharmaceuticals · NCT06056297

Look up another city

Look up another condition